NCT00165555已完成1 期
Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin and Intravenous Sodium Thiosulfate in the Multimodality Treatment of Malignant Pleural Mesothelioma
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 70
- 试验地点
- 4
- 主要终点
- To determine the maximally tolerated dose of intracavitary cisplatin in patients with malignant pleural mesothelioma,
研究概览
简要总结
The purpose of this study it to determine the safety and maximally tolerated dose (MTD) of cisplatin administered in the operating room and put into the chest and abdomen for one hour. We are also looking at the effects of heating the chemotherapy to a temperature of 42 degrees celsius.
详细描述
- Patients will undergo surgery with pleurectomy/decortication which entails the removal of the inner and outer skin of the lung, including the pleura overlying the pericardium and diaphragm. Resection of the pericardium and diaphragm are occasionally necessary to debulk the tumor. This surgery is part of standard care for pleural mesothelioma.
- After surgery, a one hour lavage with heated cisplatin will be administered to the hemithorax (and abdominal regions if the diaphragm is no longer present). The lung itself is not removed, only the diseased portion of the lung and surrounding areas with tumor.
- Immediately following the one-hour lavage, a six hour infusion of sodium thiosulfate will begin to help reduce the side effects of the cisplatin.
- Patients will remain hospitalized until they have recovered from surgery (usually 7-14 days).
- Patients will return to the hospital three months after their surgery to have fluid drawn from their chest via an ultrasound guided thoracentesis. This is called a saline wash.
- Patients will be in the study actively for three months. This includes a 2-week and 4-week post-operative follow-up in which blood work is performed. As well as a 3-month follow-up for the saline wash. Long-term follow-up includes computed tomography of the chest and abdomen every 6 months to assess recurrence.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histopathologic confirmation of malignant pleural mesothelioma
- •Patients who are able to tolerate surgical cytoreduction but unable to undergo extrapleural pneumonectomy due to poor cardiopulmonary reserve or tumor invasion
- •18 years of age or older
- •Malignancy is confined to the affected hemithorax.
- •Grossly normal cardiac function with an EKG showing no cardiomyopathy or acute changes
- •Evidence of adequate renal and hepatic function
- •Karnofsky performance status of 70% or greater
排除标准
- •Extended disease outside the ipsilateral hemithorax as determined radiologically and intraoperatively
- •Distant metastases
- •Non-malignant systemic disease
- •Active concomitant malignancy
- •Psychiatric or addictive disorders which would preclude obtaining informed consent
- •Prior treatment within the last 2 months, other than surgical resection for their current malignancy
结局指标
主要结局
To determine the maximally tolerated dose of intracavitary cisplatin in patients with malignant pleural mesothelioma,
时间窗: 3 years
次要结局
- To quantitate the safety of intraoperative intrathoracic/intraperitoneal hyperthermic cisplatin(3 years)
- to study the pharmacokinetics of cisplatin administered in this way.(3 years)
研究者
研究点 (4)
Loading locations...
相似试验
终止
2 期
Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium ThiosulfatePleural MesotheliomaMalignant Pleural MesotheliomaNCT00165503Dana-Farber Cancer Institute16
已完成
1 期
Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural MalignancyLung CancerNCT01998529M.D. Anderson Cancer Center7
Unknown
不适用
Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung CancerPleural Effusion, MalignantNCT02407912Shantou University Medical College50
已完成
1 期
Intratumoral Cisplatin for Resectable NSCLCNon-Small Cell Lung CancerNCT04809103University of Vermont6
终止
1 期
Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPMMesotheliomaNCT02838745Baylor College of Medicine7